Olon Ricerca Bioscience is thrilled to announce its upcoming participation in the annual CPHI Worldwide 2023 event, scheduled to take…
We are delighted to announce Olon Ricerca Bioscience’s participation in the highly anticipated American Association of Pharmaceutical Scientists (AAPS) Annual…
Many smaller and start-up pharma companies may have a concept of a molecule they want to develop, and they may…
At Olon Ricerca Bioscience, we value collaborating with our customers throughout the project life cycle. We understand each stage of…
In today’s ever-changing global geopolitical environment, businesses face numerous concerns about their reliance on foreign countries, particularly in East Asia.…
In the last decade, high-resolution mass spectrometry (HRMS) has emerged as a powerful technique in many fields of biological studies,…
Olon announces a new investment to further increase the production capacity, in one of the facilities dedicated to biotechnological production.…
Milan, Italy – XXX May 2023 – OLON Group, a global leader in the development and production of ac-tive pharmaceutical…
Olon, global leader in the development and production of active pharmaceutical ingredients (APIs) for CDMO and generic markets, integrating chemical…